Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 3751-3760 Newer>

BusinessWeek October 11, 2004 Gene G. Marcial	Clear Vistas at Advanced Medical Optics This manufacturer of eye surgery products isn't a household name, but its stock hit a 52-week high of 43 in late June, up from 17 in November. And a recent slide is no sign of a downturn, says one investment analyst.
BusinessWeek October 11, 2004 Gene G. Marcial	Can Axonyx Help Treat Alzheimer's? With a number of products in its pipeline and $93 million in cash, the company "heads my list in biotechs," says the top biotech analyst at Rodman & Renshaw. Its Phenserine, which is already in Phase 3 trials, may be a valuable weapon in combatting Alzheimer's.
InternetNews September 30, 2004 Sean Michael Kerner	Red Hat Takes Netscape Enterprise Red Hat will acquire parts of the Netscape Enterprise solution from AOL and has announced a stock repurchase plan that will see the company buying back up to $100 million of its securities.
The Motley Fool September 30, 2004 Phil Wohl	Family Spending Part of Its Dollar The deep-discount retail chain is feeling the effects of cautious spending.
The Motley Fool September 30, 2004 Seth Jayson	Wal-Mart of the Gods A controversial project near a Mexican archeological site yields bad P.R. for Wal-Mart. Investors need to keep an eye on public perceptions as the chain becomes ever more prominent around the globe.
The Motley Fool September 30, 2004 W. D. Crotty	Merck Chokes Back Vioxx The $2.3 billion arthritis drug is withdrawn from the market after clinical studies point to dangerous side-effects. Despite the bad news, Merck's big dividend payouts don't appear to be in jeopardy at the moment.
The Motley Fool September 30, 2004 Nathan Slaughter	Pepsi Drinks in Diverse Revenues After Coca-Cola reduces earnings guidance, Pepsi raises its outlook and beats Q2 estimates.
The Motley Fool September 30, 2004 Jeff Hwang	Fresh Del Monte's Bad Blip The company cuts its 2004 earnings outlook by 20%, citing many reasons.
The Motley Fool September 30, 2004 Seth Jayson	The New Kodak Ain't Kodak By bringing cheaper -- nearly disposable -- digital media to the consumer, SanDisk is closer to becoming this century's Kodak than Eastman Kodak itself, or its flash partner, Lexar.
The Motley Fool September 30, 2004 Alyce Lomax	Talbots Takes a Hurricane Hit The clothing retaile said that same-store sales are expected to be in the negative low to mid-single digits, with earnings coming in at $0.45 to $0.50 per share, as compared with $0.60 per share in the same quarter last year.
<Older 3751-3760 Newer> Return to current articles.